leflunomide has been researched along with Lipodystrophy, Intestinal in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kremer, AE | 1 |
| Budenhofer, U | 1 |
| Beuers, U | 1 |
| Rust, C | 1 |
| Lamparter, S | 1 |
| Dittrich, C | 1 |
| Koehler, HH | 1 |
2 other studies available for leflunomide and Lipodystrophy, Intestinal
| Article | Year |
|---|---|
[A 47-year-old dog breeder with chronic polyarthritis, weight loss and high fever].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthrit | 2008 |
Exacerbation of Whipple disease by immunosuppressants.
Topics: Aged; Diagnostic Errors; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; | 2008 |